CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 25 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,757,655 | +18.3% | 148,261 | -18.4% | 0.57% | +12.6% |
| Q3 2022 | $2,332,000 | -2.1% | 181,799 | -46.5% | 0.51% | -12.9% |
| Q2 2022 | $2,383,000 | -21.3% | 339,942 | -7.0% | 0.58% | +3.2% |
| Q1 2022 | $3,029,000 | +87.1% | 365,415 | +52.8% | 0.56% | +112.0% |
| Q4 2021 | $1,619,000 | -36.4% | 239,071 | -52.1% | 0.27% | -57.4% |
| Q1 2019 | $2,544,000 | -17.7% | 498,844 | -36.9% | 0.62% | +12.6% |
| Q4 2017 | $3,092,000 | +1589.6% | 790,872 | +1199.5% | 0.55% | +1810.3% |
| Q3 2015 | $183,000 | -80.8% | 60,858 | -73.7% | 0.03% | -74.1% |
| Q2 2015 | $954,000 | -5.1% | 231,051 | -0.5% | 0.11% | -3.4% |
| Q1 2015 | $1,005,000 | -26.3% | 232,176 | -48.1% | 0.12% | -57.4% |
| Q3 2013 | $1,363,000 | – | 446,957 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |